Malignancies of natural killer (NK) cell precursor: Myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia

Leukemia Research

Volumn 23, Issue 7, 1999, Pages 615-624

  Suzuki, Ritsuro ^a   Nakamura, Shigeo ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Acute myeloid leukemia; AML M0; CD56; CD7; Epstein Barr virus; Extramedullary leukemia; Lymphoblastic lymphoma

Indexed keywords

CD16 ANTIGEN; CD56 ANTIGEN; CD57 ANTIGEN;

ACUTE LEUKEMIA; CELL DIFFERENTIATION; CELL STRUCTURE; CHEMOTHERAPY; CYTOTOXICITY; DIFFERENTIAL DIAGNOSIS; FEMALE; GENOTYPE; HUMAN; IMMUNOPHENOTYPING; KARYOTYPE; LEUKEMIA; LYMPHOMA; MALE; NATURAL KILLER CELL; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SEX DIFFERENCE; STEM CELL;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BONE MARROW; CELL LINEAGE; CHILD; CHILD, PRESCHOOL; CYTOTOXICITY, IMMUNOLOGIC; DIAGNOSIS, DIFFERENTIAL; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE REARRANGEMENT, T-LYMPHOCYTE; GENOTYPE; HEMATOPOIETIC STEM CELLS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOPHENOTYPING; KARYOTYPING; KILLER CELLS, NATURAL; LEUKEMIA, MYELOID; LYMPHOMA, SMALL-CELL; MALE; MIDDLE AGED; PROGNOSIS; TUMOR STEM CELLS;

EID: 0033027787     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(98)00194-5     Document Type: Review

References (50)

1. Hercend T, Schmidt RE. Characteristics and uses of natural killer cells. Immunol Today 1988;9:291.
2. Fernandez LA, Pope B, Lee C, Zayed E. Aggressive natural killer cell leukemia in an adult and establishment of an NK cell line. Blood 1986;67:925.
3. Loughran TP Jr. Clonal diseases of large granular lymphocytes. Blood 1993;82:1.
4. Jaffe ES. Pathologic and clinical spectrum of post-thymic T-cell malignancies. Cancer Invest 1984;2:413.
5. Ng CS, Chan JKC, Lo STH. Expression of natural killer cell markers in non-Hodgkin's lymphomas. Hum Pathol 1987;18:1257.
6. Kern WF, Spier CM, Hanneman EH, Miller TP, Matzner M, Grogan TM. Neural cell adhesion molecule-positive peripheral T-cell lymphoma: a rare variant with a propensity for unusual sites of involvement. Blood 1992;79:2432.
7. Jaffe ES. Classification of natural killer (NK) cell and NK-like T-cell malignancies. Blood 1996;87:1207.
8. + myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity. Blood 1997;90:2417.
9. Nakamura S, Suchi T, Koshikawa T, et al. Clinicopathologic study of CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract. Am J Surg Pathol 1995;19:284.
10. Kobashi Y, Nakamura S, Sasajima Y, et al. Inconsistent association of Epstein-Barr virus with CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract. Histopathology 1996;28:111.
11. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. Proposal for the recognition of minimally differentiated acute myeloid leukemia (AML-M0). Br J Hematol 1991;78:325.
12. - myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3. Blood 1994;84:244.
13. Nathwani BN, Kin H, Rappaport H. Malignant lymphoma, lymphoblastic. Cancer 1976;38:964.
14. Reuss-Borst MA, Steinke B, Waller HD, Bühring HJ, Müller C A. Phenotypic and clinical heterogeneity of CD56-positive acute nonlymphoblastic leukemia. Ann Hematol 1992;64:78.
15. Kawano S, Tatsumi E, Yoneda N. Novel leukemic lymphoma with probable derivation from immature stage of natural killer (NK) lineage in an aged patient. Hematol Oncol 1995;13:1.
16. Dunphy CH, Gregowicz AJ, Rodriguez GJr. Natural killer cell acute leukemia with myeloid antigen expression. Am J Clin Pathol 1995;104:212.
17. Ichinohasama R, Endoh K, Ishizawa K, et al. Thymic lymphoblastic lymphoma of committed natural killer cell precursor origin. Cancer 1996;77:2592.
18. + immunophenotype of NK progenitor. Leukemia 1996;10:923.
19. + azurophilic granular T-lymphoblastic lymphoma cells. Acta Haematol Jpn 1989;52:740.
20. Adachi M, Maeda K, Takekawa M, et al. High expression of CD56 (N-CAM) in a patient with cutaneous CD4-positive lymphoma. Am J Hematol 1994;47:278.
21. Koita H, Suzumiya J, Ohshima K, et al. Lymphoblastic lymphoma expressing natural killer cell phenotype with involvement of the mediastinum and nasal cavity. Am J Surg Pathol 1997;21:242.
22. Chan JKC, Sin VC, Wong KF, et al. Nonnasal lymphoma expressing the natural killer cell marker CD56: A Clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 1997;89:4501.
23. DiGiuseppe JA, Louie DC, Williams JE, et al. Blastic natural killer cell leukemia/lymphoma: a clinicopathologic study. Am J Surg Pathol 1997;21:1223.
24. Pirruccello SJ, Bicak MS, Gordon BG, Gajl-Peczalska K, Gnarra DJ, Coccia PF. Acute lymphoblastic leukemia of NK-cell lineage: response to IL-2. Leuk Res 1989;13:735.
25. Ichikawa M, Kawai H, Komiyama A, et al. Functional p75 interleukin-2 receptor expression on the fresh blast cells in childhood acute lymphoblastic leukemia with natural killer cell properties. Am J Hematol 1991;36:259.
26. Brody JP, Allen S, Schulman P, et al. Acute agranular CD4-positive natural killer cell leukemia. Cancer 1994;75:2474.
27. Cadwell FJ, Burns CP, Dick FR, et al. Minimally differentiated acute leukemia. Leuk Res 1993;17:199.
28. Cohen PL, Hoyer JD, Kurtin PJ, Fewald GW, Hanson CA. Acute myeloid leukemia with minimal differentiation: a multi parameter study. Am J Clin Pathol 1998;109:32.
29. Villamor N, Zarco MA, Rozman M, Ribera JM, Feliu E, Montserrat E. Acute myeloblastic leukemia with minimal myeloid differentiation: phenotypical and ultrastructural characteristics. Leukemia 1998;12:1071.
30. Jaffe ES, Chan JKC, Su IJ, et al. Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas. Am J Surg Pathol 1996;20:103.
31. Woods GS, Warner NL, Warnke RA. Anti-Leu3/T4 antibodies react with cells of monocytes/macrophage and Langerhans lineage. J Immunol 1983;131:212.
32. Cleveland RP, Liu Y-C. CD4 expression by erythroid precursor cells in human bone marrow. Blood 1996;87:2275.
33. + hematopoietic progenitors express low level of CD4, the high-affinity receptor for human immunodeficiency virus-type 1. Blood 1994;84:1896.
34. Sanchez MJ, Muench MO, Roncarolo MG, Lanier LL, Phillips JH. Identification of a common T/natural killer cell progenitor in human fetal thymus. J Exp Med 1994;180:569.
35. Swerdlow SH, Habeshaw JA, Richards MA, Rainy M, Murray LJ, Stansfeld AG. T lymphoblastic lymphoma with Leu-7 positive phenotype and unusual clinical course: a multiparameter study. Leuk Res 1985;9:167.
36. Kaplan J, Ravindranath Y, Inoue S. T-cell acute lymphoblastic leukemia with natural killer cell phenotype. Am J Hematol 1996;22:355.
37. Sheibani K, Winberg CD, Burke JS, et al. Lymphoblastic lymphoma expressing natural killer cell-associated antigens: a clinicopathologic study of six cases. Leuk Res 1987;11:371.
38. +, Leu11a- acute T-lymphoblastic leukemia having low K cell activity and no NK cell activity. Am J Hematol 1987;24:101.
39. Nakamura S, Koshikawa T, Yatabe Y, Suchi T. Lymphoblastic lymphoma expressing CD56 and TdT. Am J Surg Pathol 1998;22:137.
40. Suzuki R, Seto M, Morishima M, Nakamura S. Response. Blood 1998;91:2623.
41. Oshima K, Suzumiya J, Shimazaki K, et al. Nasal T/NK cell lymphomas commonly express perfolin and Fas ligand: important mediators of tissue damage. Histopathology 1997;31:444.
42. Kawa-Ha K, Ishihara S, Ninomiya T, et al. CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. J Clin Invest 1989;84:51.
43. Hart DNJ, Baker BW, Inglis MJ, et al. Epstein-Barr viral DNA in acute large granular lymphocyte (natural killer) leukemic cells. Blood 1992;79:2116.
44. Ramsdell FJ, Golub SM. Generation of lymphokine-activated killer cell activity from human thymocytes. J Immunol 1987;139:1446.
45. Rodewald H-R, Moingeon P, Lucich JL, Dosiou C, Lopez P, Reinherz EL. A population of early fetal thymocytes expressing Fc(RII/II contains precursors of T lymphocytes and natural killer cells. Cell 1992;69:139.
46. Dorshkind K, Pollack SB, Bosma MJ, Phillips RA. Natural killer (NK) cells are present in mice with severe combined immunodeficiency (SCID). J Immunol 1985;134:3798.
47. Hackett JJr, Bosma GC, Bosma MJ, Kumar V. Transplantable progenitors of natural killer cells are distinct from those of T and B lymphocytes. Proc Natl Acad Sci USA 1986;83:3427.
48. Peter HH, Friedrich W, Dopter R, et al. NK cells function in severe combined immunodeficiency (SCID): Evidence of a common T and NK cell detect in some but not all SCID patients. J Immunol 1983;131:2332.
49. + hematopoietic progenitor cells. Blood 1995;85:3538.
50. Kaneko T, Fukuda J, Yoshihara T, Zheng H, Mori S, Mizoguchi H, Oshimi K. Nasal natural killer (NK) cell lymphoma: report of a case with activated NK cells containing Epstein-Barr virus and expressing CD21 antigen, and comparative studies of their phenotype and cytotoxicity with normal NK cells. Br J Hematol 1995;91:355.